By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) Announces Presentation Of Sublingual Sufentanil Data At The Society Of American Gastrointestinal And Endoscopic Surgeons Meeting 4/14/2015 9:41:51 AM
AcelRx (ACRX) Appoints Howard B. Rosen As Interim CEO 3/23/2015 6:33:18 AM
AcelRx (ACRX) Announces Initiation Of Pivotal Phase 3 Trial For ARX-04 3/16/2015 7:04:17 AM
AcelRx (ACRX) Reports Fourth Quarter And Full Year 2014 Financial Results 3/10/2015 7:51:53 AM
FDA Wants AcelRx (ACRX) to Run Another Trial on Zalviso Drug-Device Combo 3/9/2015 7:02:20 AM
AcelRx Pharmaceuticals (ACRX) To Hold Annual 2014 Financial Results Conference Call And Webcast On Monday, March 9th, 2015 3/4/2015 10:06:48 AM
AcelRx Pharmaceuticals (ACRX) To Participate At Two Upcoming Investor Events 2/20/2015 1:32:24 PM
AcelRx Pharmaceuticals (ACRX) To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:09:10 AM
AcelRx Pharmaceuticals (ACRX) Receives CE Mark Approval For Zalviso 12/2/2014 10:31:16 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Four Upcoming Investor Events 11/20/2014 9:27:14 AM